Geç kalınır ve ok yaydan çıkarsa, sonuçlar vahim olabilir yeniduzen.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yeniduzen.com Daily Mail and Mail on Sunday newspapers.
https://www.afinalwarning.com/485599.html (Natural News) Ahead of the first doses of the BioNTech-Pfizer COVID-19 vaccine to be administered in Germany this weekend, a creative pilot with a wild imagination and the knack for entering coordinates in his GPS logged flight hours by drawing a ‘sky syringe.’
(Article by Tyler Durden republished from ZeroHedge.com)
RT News reports pilot Samy Kramer spent a great deal of time entering the coordinates to create a syringe-shaped flight path over German skies as he needed to log flight hours.
“At the moment, I have to collect a lot of flying hours, and instead of just flying like that, I wanted to draw a reminder in the air that you should get vaccinated,” Kramer said.
En sessiz yılbaşı gecesi : Dünya, Koronavirüs le bir yılın sonunda 2021 e girmeye hazırlanıyor t24.com.tr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from t24.com.tr Daily Mail and Mail on Sunday newspapers.
Aditi Tandon
New Delhi, December 30
The UK regulator on Wednesday approved the Oxford University Astra Zeneca COVID-19 vaccine for emergency use in its population a day after the country reported a whopping 40,000 new cases as it reeled under the impact of a new more infectious mutant strain.
India has yet to give its approval to the vaccine. The Drug Controller of India, which held a meeting on a pending application from Serum Institute of India for emergency use approval of the vaccine, asked for more data from the SII as well as Bharat Biotech.
Serum Institute is the production collaborator for the Oxford vaccine and has readied millions of doses for rollout the moment emergency use approval comes.
Dec 30 2020 Read 676 Times
The UK Government has today (Dec 30) accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK.
The Joint Committee on Vaccination and Immunisation (JCVI) will also publish its latest advice for the priority groups to receive this vaccine, with this announcement indicating that the JCVI has advised the priority should be to give as many people in at-risk groups their first dose, rather than providing the required two doses in as short a time as possible.
The second dose completes the course and is important for longer term protection, and everyone will still receive their second dose within 12 weeks of their first, an approach the JCVI believes will maximise the maximise the benefits of this vaccine, ensuring at-risk people are able to get meaningful protection and ease the pressure on the UK National Health Service.